← Back to Psychology

Biomedical treatment and the treatment landscape

Biomedical treatments act directly on the brain and body. Choosing among treatments depends on research evidence, the person's preferences, and access to care. This lesson is for learning about psychology, not for diagnosing yourself or anyone else; if you are struggling, talk to a qualified professional.

Evaluating therapies

Because many disorders improve over time and people seek help when they feel worst, some improvement may be regression towards the mean or placebo effects. Controlled studies and meta-analyses, statistical summaries of many studies, show that psychotherapy is generally effective: the average person in therapy is better off than most untreated people. Evidence-based practice integrates research, clinical expertise, and the client's characteristics and preferences.

Antidepressants

Antidepressants include selective serotonin reuptake inhibitors (SSRIs), such as fluoxetine (Prozac, approved in the United States in 1987), which increase serotonin availability by blocking its reuptake. They are used for depression, anxiety disorders, OCD, and PTSD. Effects usually take several weeks, and people should start, change, or stop them only with medical guidance. For mild depression, effects over placebo are modest; for severe depression they are larger.

Antipsychotics and mood stabilisers

Antipsychotic drugs, beginning with chlorpromazine in the 1950s, reduce positive symptoms of schizophrenia, largely by blocking dopamine receptors; long-term use of older drugs can cause tardive dyskinesia, involuntary movements. Newer (atypical) antipsychotics have different side effects, such as weight gain. Lithium, a mood stabiliser, reduces mood swings in bipolar disorder and is associated with lower suicide risk.

Anti-anxiety drugs

Benzodiazepines, such as diazepam (Valium) and alprazolam (Xanax), depress central nervous system activity and reduce anxiety quickly. They can be habit-forming and may interfere with learning to cope through exposure, so they are generally prescribed for short periods. SSRIs and CBT are often preferred for long-term treatment of anxiety disorders.

Brain stimulation

Electroconvulsive therapy (ECT), delivering a brief electric current to the brain of an anaesthetised patient, can be effective for severe depression that has not responded to other treatments, though it may cause short-term memory loss; it is far safer and more humane than the early procedures depicted in films. Repetitive transcranial magnetic stimulation (rTMS) uses magnetic pulses to stimulate brain areas and is used for depression. Deep brain stimulation is experimental for some conditions.

Psychosurgery and its history

Psychosurgery removes or destroys brain tissue. Egas Moniz developed the lobotomy in the 1930s, cutting connections to the frontal lobes, and shared the 1949 Nobel Prize; tens of thousands of lobotomies were performed, often leaving people permanently impaired. The procedure fell out of use after antipsychotic drugs appeared in the 1950s. Today, very precise neurosurgery is used only rarely, for severe cases that have not responded to other treatment.

Lifestyle and prevention

Healthy behaviours support mental health: regular aerobic exercise can ease mild to moderate depression and anxiety; adequate sleep, social connection, time in nature, and good nutrition also help. Prevention efforts aim to reduce risk factors, such as poverty, abuse, and isolation, and to build resilience. Deinstitutionalisation, moving people out of large psychiatric hospitals from the 1950s onwards, improved freedom but left many without adequate community care.

Access to care

Many people with disorders never receive treatment, especially in low-income countries, where the World Health Organization reports large treatment gaps. Barriers include cost, stigma, and shortages of trained professionals. Teletherapy, school and workplace programmes, task-sharing with trained community workers, and crisis lines such as 988 in the United States aim to widen access. Culturally sensitive therapy considers clients' backgrounds and values.

Key takeaways

Controlled studies and meta-analyses show psychotherapy is generally effective beyond placebo and regression to the mean; evidence-based practice combines research, expertise, and client preferences. SSRIs such as fluoxetine (1987) treat depression and anxiety, take weeks, and must be managed medically. Antipsychotics, beginning with chlorpromazine in the 1950s, block dopamine; lithium stabilises bipolar mood. Benzodiazepines relieve anxiety quickly but can be habit-forming. ECT helps severe treatment-resistant depression; rTMS and deep brain stimulation are newer options. Moniz's lobotomy (Nobel 1949) caused great harm and was abandoned. Exercise, sleep, social connection, and prevention support mental health. Treatment gaps persist; teletherapy, community workers, and crisis lines widen access.

Flashcard

Meta-analysis

Statistical summary of many studies

Evaluating therapy.

Check your understanding

Why might a person seem to improve after therapy even if the therapy had no effect?

Take the unit quiz

← Previous lesson